Data / Form D filings / RHEONIX INC
RHEONIX INC: Form D filings
RHEONIX INC, a biotechnology company in Ithaca, NY, filed 6 Form D notices with the SEC between 2010 and 2020. The latest, on June 18, 2020, reports an offering of no set size with nothing sold yet.
Find out what RHEONIX INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10 Brown Road, Suite 103, Ithaca, NY, 14850
- Phone
- (607) 257-1242
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1454559
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 18, 2020 | New notice | Indefinite | $0 | Indefinite | 0 | Yet to occur | sec.gov |
| Oct 9, 2015 | New notice | $36,500,000 | $21,862,496 | $14,637,504 | 24 | Sep 29, 2015 | sec.gov |
| Dec 19, 2013 | Amendment | $12,000,000 | $12,000,000 | $0 | 51 | Oct 25, 2013 | sec.gov |
| Dec 2, 2013 | New notice | $6,000,000 | $6,000,000 | $0 | 51 | Oct 25, 2013 | sec.gov |
| Feb 14, 2012 | New notice | $6,000,000 | $6,000,000 | $0 | 54 | Feb 9, 2012 | sec.gov |
| Jan 14, 2010 | New notice | $11,524,758 | $11,524,758 | $0 | 54 | Dec 30, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Smith | Executive Officer | |
| Gregory Galvin | Executive Officer | |
| John Albert Brenner | Executive Officer |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Jun 15, 2020 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what RHEONIX INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.